Aemetis, Inc. (NASDAQ:AMTX) Receives $12.95 Consensus Target Price from Analysts

Aemetis, Inc. (NASDAQ:AMTX) has received a consensus recommendation of “Moderate Buy” from the five research firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price target among analysts that have covered the stock in the last year is $12.95.

A number of equities analysts recently issued reports on AMTX shares. HC Wainwright restated a “buy” rating and issued a $28.00 target price on shares of Aemetis in a research note on Friday, November 15th. Ascendiant Capital Markets dropped their price objective on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a report on Tuesday, September 3rd. Finally, UBS Group cut their price target on Aemetis from $8.25 to $7.75 and set a “buy” rating on the stock in a research report on Monday, August 19th.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. FMR LLC grew its position in Aemetis by 68.2% in the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after acquiring an additional 9,137 shares in the last quarter. Hutchinson Capital Management CA purchased a new stake in Aemetis during the 2nd quarter worth approximately $70,000. Barclays PLC lifted its holdings in Aemetis by 274.6% during the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after buying an additional 34,816 shares in the last quarter. Rhumbline Advisers boosted its position in Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock valued at $157,000 after buying an additional 50,528 shares during the period. Finally, Wellington Management Group LLP acquired a new position in shares of Aemetis in the third quarter worth $177,000. Institutional investors and hedge funds own 27.02% of the company’s stock.

Aemetis Stock Performance

Shares of NASDAQ:AMTX opened at $3.01 on Thursday. The business has a 50-day simple moving average of $3.29 and a two-hundred day simple moving average of $3.02. The firm has a market cap of $149.72 million, a price-to-earnings ratio of -1.33 and a beta of 1.35. Aemetis has a fifty-two week low of $2.10 and a fifty-two week high of $7.03.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The company had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same quarter in the previous year, the company posted ($0.59) earnings per share. As a group, research analysts predict that Aemetis will post -2.02 earnings per share for the current year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.